The gastrointestinal infection testing market is bound to witness a CAGR of 4.9% and US$ 490.2 Mn between 2018-2026. The current scenario is such that technology is making inroads into the healthcare vertical, which is, in turn, reducing the cumbersome, in-person interactions with the caregiver. Telehealth is expected to outlive physical meetings in the forecast period. This would be the state of the healthcare vertical going forward.
According to the NCBI (National Center for Biotechnology Information), around 200 million GI illnesses occur in the United States each year. Gastrointestinal infection testing is performed to detect bacteria, viruses, and parasites. The growing frequency of gastrointestinal illnesses is increasing the number of Gastrointestinal Infection Testing, which will drive the growth of the gastrointestinal infection testing market over the forecast period.
Persistence Market Research’s (PMR) recent report says that the global gastrointestinal infection testing market is expected to hit US$ 490.2 Mn by 2026. The gastrointestinal infection testing market is expected to have a CAGR of 4.9% during the forecast period of 2022-2026, according to the report.
Get a Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/17314
Company Profiles:
- Becton, Dickinson and Company (BD)
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Luminex Corporation
- Hoffmann-La Roche Ltd.
- bioMérieux SA
- Quidel Corporation
- Illumina, Inc.
- Seegene Inc
- Genetic Signatures
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/17314
The Asia Pacific Region, Excluding China, will have the Highest Growth Rate
The Asia Pacific region, excluding China, is projected to have the highest growth rate because of a rising patient pool due to unhealthy lifestyles and inadequate sanitation facilities.
Apart from the Asia-Pacific region, the gastrointestinal infection testing market in North America is also expected to contribute to the global gastrointestinal infection testing market’s growth due to the rising healthcare budget and initiatives to increase awareness and availability of quality gastrointestinal infection testing options in the region. However, the US FDA’s stringent rules and regulations may impede the growth of the gastrointestinal infection testing market in this region.
The Impact of COVID-19 on the Global Gastrointestinal Infection Testing Market
In 2020, as COVID-19 cases began to peak, there was a decrease in the number of gastrointestinal infection testing due to Covid-19 restrictions and lockdowns. However, in 2021, when the Covid-19 restrictions were relaxed, the Gastrointestinal Infection Testing frequency began to rise.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/17314
Want More Insights?
PMR has presented a comprehensive report based on Gastrointestinal Infection Testing Market as per Product Type (Reagent Kits, Sequencing Kits, and Equipment), Disease Strains (Bacterial Strains, Viral Strains and Parasitic Strains), End User (Hospitals, Clinics/Medical Centers, Diagnostic Laboratories and Research Institutes), based on seven regions.
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com